HEALTHPOINT Canada, a division of HEALTHPOINT Ltd., , began marketing COOK Biotech Incorporated's patented wound matrix product, Oasis, in Canada this month through a distribution partnership with Trudell Medical Marketing Limited. More
Two new studies on the Efficacy, Tolerability and Safety of Kortos® HC cream and Kortos® HC Suppository have been carried out, found to be highly efficacous and well tolerated with no clinically relevant systemic or local side/adverse effects More
Healthpoint Ltd. has announced that the United States Patent and Trademark Office has granted Healthpoint a Notice of Allowance on its patent application for the ointment vehicle that is the basis for Healthpoint's Xenaderm(tm). More
Rapid In-vitro Percutaneous Penetration Profile of Sulidin® 1% Nimesulide LPS topical gel to be presented at the 8'th International Conference on Percutaneous Penetration. More
Dr Duncan Aust joins one of the fastest growing R & D groups in the industry: Dedicated to dermatology, skin diseases and wound and tissue management. More